Data as of 1:32pm ET
| +0.0369 / +1.25%|
BioTime, Inc. is a biotechnology company, which is focused on regenerative medicine and blood plasma volume expanders. The company provides research and product development in the field of regenerative medicine. It develops blood plasma volume expanders, blood replacement solutions for hypothermic surgery and technology for use in surgery, emergency trauma treatment and other applications. The company focuses in the field of emerging field of regenerative medicine; specifically human embryonic stem cell and induced pluripotent stem cell technology. BioTime was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Alameda, CA.
|Michael D. West||President, Chief Executive Officer & Director|
|Robert W. Peabody||Senior VP, Chief Operating & Financial Officer|
|Hal Sternberg||Vice President-Research|
|Judith Segall||Secretary, Director & VP-Administration|
|William P. Tew||Chief Commercial Officer|